CBD made aggressive breast cancer cells more vulnerable to immune cell attack
CBD inhibited EGFR signaling in triple-negative breast cancer cells and increased a death receptor on their surface, making them significantly more susceptible to killing by natural killer immune cells.
Quick Facts
What This Study Found
CBD elevated FAS death receptor expression on MDA-MB-468 cells to 125% versus 83% with EGF alone, and enhanced NK-92 cell cytotoxicity, reducing cancer cell viability to 52% versus 114% with EGF alone. CBD downregulated KRAS, PI3K, and AKT.
Key Numbers
FAS expression: 125.29% with CBD vs. 83.07% with EGF alone (p<0.0001). Cancer cell viability with NK cells: 52.12% with CBD vs. 113.69% with EGF alone (p<0.0001).
How They Did This
In vitro study using two TNBC cell lines (MDA-MB-468 and MDA-MB-231) treated with CBD in the presence or absence of epidermal growth factor.
Why This Research Matters
Triple-negative breast cancer lacks targeted therapies. If CBD can make these cancer cells more visible to the immune system by upregulating death receptors and suppressing growth signaling, it could complement immunotherapy.
The Bigger Picture
Immunotherapy has transformed cancer treatment but works poorly in TNBC. Finding compounds that sensitize TNBC cells to immune attack is a major research priority.
What This Study Doesn't Tell Us
In vitro study only; no animal or human data. CBD showed potential cytotoxicity to immune cells at certain concentrations.
Questions This Raises
- ?At what concentrations does CBD become toxic to NK cells?
- ?Would CBD enhance immunotherapy outcomes in TNBC animal models?
Trust & Context
- Key Stat:
- cancer cell viability with NK cells: CBD-treated cells were far more susceptible to immune killing than EGF-treated controls
- Evidence Grade:
- Cell culture study with strong statistical significance but no in vivo validation. Results are promising but very early-stage.
- Study Age:
- 2025 publication.
- Original Title:
- Cannabidiol sensitizes triple-negative breast cancer cells to NK cell-mediated killing via EGFR inhibition and FAS upregulation.
- Published In:
- Journal of cannabis research, 7(1), 85 (2025)
- Authors:
- Garunyapakun, Perawat, Ramwarungkura, Boonyanuch, Natungnuy, Krissada, Turbpaiboon, Chairat, Yenchitsomanus, Pa-Thai, Junking, Mutita
- Database ID:
- RTHC-06513
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is triple-negative breast cancer?
TNBC lacks three receptors (estrogen, progesterone, HER2) that most breast cancer drugs target, making it harder to treat. It accounts for about 15% of breast cancers.
How did CBD make cancer cells more vulnerable?
CBD increased expression of FAS, a "death receptor" on cancer cells that immune cells use to trigger cancer cell suicide. Simultaneously, CBD shut down the EGFR growth signaling pathway.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-06513APA
Garunyapakun, Perawat; Ramwarungkura, Boonyanuch; Natungnuy, Krissada; Turbpaiboon, Chairat; Yenchitsomanus, Pa-Thai; Junking, Mutita. (2025). Cannabidiol sensitizes triple-negative breast cancer cells to NK cell-mediated killing via EGFR inhibition and FAS upregulation.. Journal of cannabis research, 7(1), 85. https://doi.org/10.1186/s42238-025-00340-5
MLA
Garunyapakun, Perawat, et al. "Cannabidiol sensitizes triple-negative breast cancer cells to NK cell-mediated killing via EGFR inhibition and FAS upregulation.." Journal of cannabis research, 2025. https://doi.org/10.1186/s42238-025-00340-5
RethinkTHC
RethinkTHC Research Database. "Cannabidiol sensitizes triple-negative breast cancer cells t..." RTHC-06513. Retrieved from https://rethinkthc.com/research/garunyapakun-2025-cannabidiol-sensitizes-triplenegative-breast
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.